Jianmin Liu

169 Donghu Road
Wuhan, 430071, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Pleiotrophin modulates cell proliferation, prostate smooth muscle contraction and fibrosis in hyperplastic prostate.

Pleiotrophin modulates cell proliferation, prostate smooth muscle contraction and fibrosis in hyperplastic prostate.

Journal: Journal of translational medicine

Published: May 15, 2025

FBXW7/GSK3β-mediated proline-rich 11 degradation promotes oxidative DNA damage and inhibits tumor progression in renal cell carcinoma.

FBXW7/GSK3β-mediated proline-rich 11 degradation promotes oxidative DNA damage and inhibits tumor progression in renal cell carcinoma.

Journal: Theranostics

Published: October 30, 2024

Broad and diverse roles of sphingosine-1-phosphate/sphingosine-1-phosphate receptors in the prostate.

Broad and diverse roles of sphingosine-1-phosphate/sphingosine-1-phosphate receptors in the prostate.

Journal: iScience

Published: July 10, 2024

Deubiquitylase USP52 Promotes Bladder Cancer Progression by Modulating Ferroptosis through Stabilizing SLC7A11/xCT.

Deubiquitylase USP52 Promotes Bladder Cancer Progression by Modulating Ferroptosis through Stabilizing SLC7A11/xCT.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: April 16, 2024

S100A4 modulates cell proliferation, apoptosis and fibrosis in the hyperplastic prostate.

S100A4 modulates cell proliferation, apoptosis and fibrosis in the hyperplastic prostate.

Journal: The international journal of biochemistry & cell biology

Published: September 16, 2023

STEAP4 modulates cell proliferation and oxidative stress in benign prostatic hyperplasia.

STEAP4 modulates cell proliferation and oxidative stress in benign prostatic hyperplasia.

Journal: Cellular signalling

Published: June 18, 2023

Fibronectin-1: A Predictive Immunotherapy Response Biomarker for Muscle‑Invasive Bladder Cancer.

Fibronectin-1: A Predictive Immunotherapy Response Biomarker for Muscle‑Invasive Bladder Cancer.

Journal: Archivos espanoles de urologia

Published: March 13, 2023

Simvastatin Improves Benign Prostatic Hyperplasia: Role of Peroxisome-Proliferator-Activated Receptor-γ and Classic WNT/β-Catenin Pathway.

Simvastatin Improves Benign Prostatic Hyperplasia: Role of Peroxisome-Proliferator-Activated Receptor-γ and Classic WNT/β-Catenin Pathway.

Journal: International journal of molecular sciences

Published: January 30, 2023

Expression and functional activity of myosin II in hyperplastic prostates of varying volumes.

Expression and functional activity of myosin II in hyperplastic prostates of varying volumes.

Journal: Cellular signalling

Published: December 31, 2022

Identification of Hub Genes Associated with Progression and Prognosis of Bladder Cancer by Integrated Bioinformatics Analysis.

Identification of Hub Genes Associated with Progression and Prognosis of Bladder Cancer by Integrated Bioinformatics Analysis.

Journal: Archivos espanoles de urologia

Published: December 06, 2022

The Emerging Role of Cell Adhesion Molecules on Benign Prostatic Hyperplasia.

The Emerging Role of Cell Adhesion Molecules on Benign Prostatic Hyperplasia.

Journal: International journal of molecular sciences

Published: November 18, 2022

Changes in the Expression and Functional Activities of C-X-C Motif Chemokine Ligand 13 (CXCL13) in Hyperplastic Prostate.

Changes in the Expression and Functional Activities of C-X-C Motif Chemokine Ligand 13 (CXCL13) in Hyperplastic Prostate.

Journal: International journal of molecular sciences

Published: October 30, 2022

Showing 1-12 of 25

Last Updated: 09/26/2026